- Research article
- Open Access
- Open Peer Review
Risk reduction before surgery. The role of the primary care provider in preoperative smoking and alcohol cessation
BMC Health Services Researchvolume 10, Article number: 121 (2010)
Daily smokers and hazardous drinkers are high-risk patients, developing 2-4 times more complications after surgery. Preoperative smoking and alcohol cessation for four to eight weeks prior to surgery halves this complication rate. The patients' preoperative contact with the surgical departments might be too brief for the hospital to initiate these programmes. Therefore, it was relevant to evaluate a new clinical practice which combined the general practitioner's (GP) referral to surgery with a referral to a smoking and alcohol intervention in the surgical pathway.
The design was an exploratory prospective trial. The outcome measured was the number of patients referred to a preoperative smoking and alcohol cessation programme at the same time as being referred for elective surgery by their GP. The participants consisted of 72 high-risk patients who were referred for elective surgery by 47 local participating GPs.
The GPs, nurses, and specialists in internal medicine, prehabilitation and surgery developed new clinical practice guidelines based on the literature and interviews with 11 local GPs about the specific barriers for implementing a smoking and alcohol cessation programme. The role of the GP was to be the gatekeeper: identifying daily smokers and hazardous drinkers when referring them to surgery; handing out information on risk reduction; and referring those patients identified to a preoperative smoking and alcohol cessation programme. The role of the hospital was to contact these patients to initiate smoking and alcohol cessation at the hospital out-patient clinic for life-style intervention.
The GPs increased their referral to the smoking and alcohol cessation programme from 0% to 10% (7/72 patients) in the study period.
The effect of the study was limited in integrating the efforts of primary care providers and hospital surgical departments in increasing the up-take of preoperative smoking and alcohol cessation programmes aimed at smokers and harmful drinkers referred for surgery. New strategies for cooperation between GPs and surgical departments are urgently needed.
J.nr. 2005-54-1781 in Danish Data Protection Agency.
J.nr. 07 268136 in Scientific Ethical Committee for Copenhagen and Frederiksberg Municipalities.
Daily smoking and harmful alcohol intake increases the development of postoperative complications by two to four times [1–4]. The most frequent problems after surgery for smokers are wound and pulmonary complications; for harmful drinkers it is infections, bleeding episodes, cardiopulmonary insufficiency and death [1–4].
It is well documented that preoperative smoking and drinking cessation programmes of 4-8 weeks duration, significantly reduce the increased risk of complications after surgery [5–7]. Yet, short programmes have not been shown to have any effect on the surgical outcomes, probably because they are followed by poorer tobacco and alcohol cessation rates [8–10]. Recent studies considered the 4-8 weeks preoperative intervention to be cost-effective [11, 12], and furthermore the patients were considered to be positive and motivated to undertake preoperative lifestyle changes in high quality programmes at the hospital .
Currently, preoperative smoking and alcohol cessation are recommended as standard operating procedures for both smokers and hazardous drinkers scheduled for elective surgery [1, 2, 14–17]. However, the preoperative contact with the hospital may often be too short for the patient to fulfil a preoperative lifestyle intervention programme of 4-8 weeks without postponing the date of surgery. Thus the involvement of the referring general practitioner (GP) becomes relevant.
It is well-known that the GP plays an important role in smoking and alcohol intervention programmes. However, several barriers have been identified which prevent GPs' engaging in lifestyle interventions, especially smoking cessation intervention [18–22] (Table 1); further local barriers may also exist.
Our hypothesis was that GPs engaged under attractive conditions would refer more high-risk patients to lifestyle intervention programmes prior to surgery. Our aim was to evaluate a new integrated clinical practice for daily smokers and hazardous drinkers admitted for elective surgery.
The study was an exploratory prospective trial, evaluating "before and after" outcomes in a clinical setting.
This study was approved by the Quality Committee of GPs in Copenhagen and the quality management at our hospital. The study was also approved by the Danish Data Protection Agency and reported to the Scientific Ethical Committee System. It was not necessary to seek patient consent, since according to Danish Policy the intervention was aimed at the implementation of guidelines, involving only doctors, nurses, and the organisation.
Development of integrated guidelines and material
A working group with key representatives from the local GPs, surgeons and nurses; Tobacco Cessation Clinic; Alcohol Unit; and Clinical Unit of Health Promotion was formed to develop the new integrated guideline for lifestyle intervention prior to surgery (Figure 1). This integrated guideline was based on the most recent evidence, which was exclusively gathered in hospital settings [1, 4–7].
The working group decided how they would monitor the high-risk patient's preoperative route to surgery and give feedback (Additional file 1). They also developed a pack of materials for the GPs and surgeons. This pack consisted of: a folder describing how to identify high-risk patients; evidence of the effect of preoperative risk reduction programmes; recommendations for preoperative abstinence; and the procedure for referral to the hospital lifestyle intervention programme. Furthermore, the group developed a patient information folder (common to both the hospital and GPs). An information letter, the integrated guidelines and folder of material were sent to all 199 local GPs. The authors gave interviews to medical newspapers and web-portals about the project. The focus was on removing barriers to implementation by emphasising the benefits of the programme for the patient, and the simplicity of the referral procedure and the attractive reimbursement for the GPs, (The GPs received an additional 1/3 reimbursement per patient for identifying, informing and referral).
However, a few months after the start of the programme only two patients had been referred. In order to improve the referral rate, 11 of the first 12 GPs recruited to the project participated in a telephone interview regarding local barriers and facilitators for referral, as well as discussing further GP engagement and incentives. (Table 2) The resulting suggestions concerned patient-oriented efforts, such as an article in the local newspaper, free folders and posters in the clinic. The GP-oriented efforts included personal feedback every month; email reminders; a website; information at the doctor's desk; telephone calls; and involving the practice secretary. All the suggestions were subsequently taken up.
The outcome parameter was the number of high-risk patients referred by GPs to the smoking and alcohol intervention programmes prior to surgery.
Prior to this study no high-risk patients had been referred to preoperative lifestyle intervention programmes by the local GPs.
72 high-risk patients, over a period of nine months, were referred for elective surgery at the departments of orthopaedic surgery and surgical gastroenterology by 47 local GPs who had volunteered to participate in the study. These 47 GPs had been recruited from 199 GPs based in the local community, by postal invitation and personal telephone calls. There were no exclusion criteria for recruiting local GPs.
In total, 301 patients were admitted via the GPs throughout the study period for surgery. According to the preoperative surgical records, 57 of these 301 patients smoked daily (=19%) and 27 (9%) drank hazardously, including 12 patients who did both. The history of alcohol intake was unknown in 73 (=24%) patients, and the history of smoking was unknown in 68 (23%), (Figure 2). Only 7, of the identified 72, high-risk patients referred for elective surgery were also referred to preoperative smoking and alcohol intervention programmes. The 7 patients were referred by 7 different GPs (two of which belonged to the group of 11 interviewed GPs). The referrals were distributed over the total inclusion period. The GPs did not report any patients who were offered referral to the programme but refused.
In this study, we were only able to show a small increase, from zero to ten percent, in the frequency of patients directly referred by GPs to the surgical departments and the hospital's preoperative smoking and alcohol cessation programme. Though a ten percent increase in some situations is of importance, this low referral rate would not be acceptable in case of surgery from a patient safety view. This is because ninety percent of the high-risk patients that could benefit from a timely risk reduction are overlooked.
It was surprising that overcoming the barriers known to be related to GPs' assessment and counselling for tobacco cessation [23–37], did not facilitate the referral of high-risk patients in our study.
We discovered that in spite of a positive attitude among the GPs, as well as approval and support from their organisation, the referral rate was very low.
It might be speculated that this poor referral rate was due to patients refusing to be referred when offered this option by their GPs. However we discovered that this was not the case in the present study. We learnt in interviews with the GPs, that in daily practice, they forgot to play their role in risk reduction before surgery. In view of this the GPS asked for more information and reminders for both the patients and themselves. However, meeting these local wishes and suggestions did not result in an increased number of referred patients.
Bias and limitations
Some of the elements in the integrated preoperative programme that had been identified in interviews or from previous studies as possible barriers have not yet been subjects for specific intervention research. They may therefore, theoretically, be of minor significance, which would reduce the effect of overcoming them. Another theoretical possibility could be that some of the efforts to overcome the barriers might have a negative effect and thereby neutralise a positive effect from other elements in the integrated programme. Furthermore, some barriers may be of greater importance in different countries; e.g. the simple referral model and easy access to smoking cessation experts has been shown to be effective among GPs in England , but not in the Netherlands . The factors given in table 1 originated from Europe, North America and Australia; however, it is unclear whether the individual factors are specific to concrete contexts or health-care systems. The extra reimbursement for the GP reflected the "pay per service" or "quality-based reimbursement principle", which seemed promising in some studies, but not in others . One other explanation for the poor referral rate could be that it is unusual tradition to have such integrated collaboration regarding risk reduction by changing lifestyle for surgical patients.
The tight time schedule imposed by the requirements of the integrated preoperative programme prior to surgery, could pose a significant challenge for GP's. In other situations the "window of intervention" for smoking and hazardous drinking may either be open longer or there is an opportunity to repeat the intervention programmes, for example in patients with COPD, diabetes, liver diseases etc.
Furthermore, the legal responsibility for the surgical pathway may play a role. According to the law in most countries the surgeon is the person responsible for having informed the patient sufficiently before surgery regarding the benefits and harms of that surgery. This is necessary to ensure that the patient has the correct basis for giving their informed consent to the operation.
The clinical perspective
From a clinical point of view, integration of a preoperative smoking and alcohol cessation intervention in the surgical pathway is highly desirable. The effective preoperative lifestyle intervention programmes published hitherto either took place in the hospital out-patient clinics or in units in close relation to the surgical pathway and were given by experts [5–7].
In the long-term it would be relevant to establish a better tradition for collaboration between the primary care providers and the surgical departments. In the short-term it is, however, important to evaluate other strategies for risk reduction to offer the programmes in due time before surgery. Otherwise the consequences would be tremendous for the patient and for the healthcare system in general. In Denmark the annual costs related to the increased complications rate and prolonged hospital stay among harmful drinkers without preoperative lifestyle intervention programmes are approximately 30-50 Euros per capita . The corresponding amount for smokers may be similar. The preoperative smoking intervention has already proven cost-effective in the immediate postoperative period [11, 12].
The implementation of this programme may also arise from a political level, which may decide that all high-risk patients on waiting lists for elective operations should be offered a lifestyle intervention programme prior to surgery .
The patient perspective
From a patient perspective, patients, relatives and patient organisations need improved information regarding the high-risk of surgery and the effectiveness of risk reduction programmes prior to surgery. Though smokers and hazardous drinkers undergoing surgery may never develop into a strong and demanding patient organisation, they may complain about misinformation or lost opportunities to improve their surgical outcomes in the future.
The research perspective
This study gives rise to a hypothesis that overcoming identified barriers (table 1) are insufficient when implementing new integrated guidelines. It might be necessary to add new elements that can stimulate GPs to remember to follow the guidelines in their daily practice.
In addition, new research could change the emphasis from projects investigating barriers to exploration of fully implemented and integrated procedures in primary and secondary care. This may help to generate new strategies for implementation among surgical drinking and smoking patients.
In conclusion, we did not succeed in using a programme integrating the efforts of the primary care providers and the hospital for risk reduction in the preoperative period aimed at smokers and harmful drinkers referred for surgery. Development, and evaluation, of new strategies for cooperation between primary care providers and surgical departments are urgently required in order to offer intervention programmes in a timely fashion before elective operations and to fulfil surgical obligations and responsibilities.
Tønnesen H, Nilsen PR, Lauritzen JB, Møller AM: Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth. 2009, 102: 297-306. 10.1093/bja/aen401.
Warner DO: Preoperative abstinence from cigarettes. Anesthesiology. 2006, 104: 356-67. 10.1097/00000542-200602000-00023.
Tønnesen H: Alcohol abuse and postoperative morbidity. Dan Med Bull. 2003, 50: 139-60.
Thomsen T, Tønnesen H, Møller AM: Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. Br J Surg. 2009, 96: 451-61. 10.1002/bjs.6591.
Møller AM, Villebro N, Pedersen T, Tønnesen H: Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet. 2002, 359: 114-7. 10.1016/S0140-6736(02)07369-5.
Tønnesen H, Rosenberg J, Nielsen HJ, Rasmussen V, Hauge C, Pedersen IK, Kehlet H: Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ. 1999, 318: 1311-6.
Lindström D, Sadr Azodi O, Wladis A, Tønnesen H, Linder S, Nasell H, et al: Effects of a perioperative smoking cessation intervention on postoperative complications: A randomized trial. Ann Surg. 2008, 248: 739-45. 10.1097/SLA.0b013e3181889d0d.
Sørensen LT, Hemmingsen U, Jørgensen T: Strategies of smoking cessation intervention before hernia surgery--effect on perioperative smoking behavior. Hernia. 2007, 11: 327-33. 10.1007/s10029-007-0229-0.
Sørensen LT, Jørgensen T: Short-term pre-operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial. Colorectal Dis. 2003, 5: 347-52. 10.1046/j.1463-1318.2003.00450.x.
Shourie S, Conigrave KM, Proude EM, Ward JE, Wutzke SE, Haber PS: The effectiveness of a tailored intervention for excessive alcohol consumption prior to elective surgery. Alcohol Alcohol. 2996, 41: 643-9.
Hejblum G, Atsou K, Dautzenberg B, Chouaid C: Cost-benefit analysis of a simulated institution-based preoperative smoking cessation intervention in patients undergoing total hip and knee arthroplasties in France. Chest. 2009, 135: 477-83. 10.1378/chest.08-0897.
Møller AM, Kjellberg J, Pedersen T: Health economic analysis of smoking cessation prior to surgery--based on a randomised trial. Ugeskr Laeger. 2006, 168: 1026-30. (English abstract)
Boel T, Kannegaard PN, Goldstein H, Andersen T: Smoking, alcohol overconsumption and obesity before elective surgery. Prevalence and patient motivation for risk reduction. Ugeskr Laeger. 2004, 166: 3297-300. (English abstract)
Murin S: Smoking Cessation Before Lung Resection. Chest. 2005, 127: 1873-5. 10.1378/chest.127.6.1873.
Warner DO: Preoperative smoking cessation: how long is long enough?. Anesthesiology. 2005, 102: 883-4. 10.1097/00000542-200505000-00003.
Barrera R, Shi W, Amar D, Thaler HT, Gabovich N, Bains MS, White DA: Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest. 2005, 127: 1977-83. 10.1378/chest.127.6.1977.
Spies C, Tønnesen H, Andreasson S, Helander A, Conigrave K: Perioperative morbidity and mortality in chronic alcoholic patients. Alcoholism. Clinical and Experimental Research. 2001, 25: 164S-170S.
Litt J: Smoking and GPs: Time to cough up: Successful interventions in general practice. Aust Fam Physician. 2005, 34: 425-9.
Litt J: How to provide effective smoking cessation advice in less than a minute without offending the patient. Aust Fam Physician. 2002, 31: 1087-94.
Vogt F, Hall S, Marteau TM: General practitioners' and family physicians' negative beliefs and attitudes towards discussing smoking cessation with patients: A systematic review. Addiction. 2005, 100: 1423-31. 10.1111/j.1360-0443.2005.01221.x.
Jackson G, Bobak A, Choriton I, Fowler G, Hall R, Khimji H, Matthews H, Stapleton J, Steele C, Stillman P, Sutherland G, Swanson RH: Smoking cessation: A consensus statement with special reference to primary care. Int J ClinPract. 2002, 55: 385-92.
Zwar NA, Richmond RL: Role of the general practitioner in smoking cessation. Drug Alcohol Rev. 2006, 25: 21-6. 10.1080/09595230500459487.
Helgason AR, Lund KE: General Practitioners' perceived barriers to smoking cessation - results from four Nordic countries. Scand J Public Health. 2002, 30: 141-7.
McEwen A, Akotia N, West R: General Practitioners' views on English national smoking cessation guidelines. Addiction. 2001, 96: 997-1000. 10.1046/j.1360-0443.2001.9679978.x.
O'Loughlin J, Makni H, Tremblay M, Lacroix C, Gervais A, Dery V, Meshefedjian G, Paradis G: Smoking cessation counselling practices of general practitioners in Montreal. Prev Med. 2001, 33: 627-38. 10.1006/pmed.2001.0937.
Young JM, Ward JE: Implementing guidelines for smoking cessation advice in Australian general practice: Opinion, current practice, readiness to change and perceived barriers. Fam Pract. 2001, 18: 14-20. 10.1093/fampra/18.1.14.
Prignot J, Bartsch P, Vermeire P, Jamart J, Wanlin M, Uydebrouck M, Thijs J: Physician's involvement in the smoking cessation process of their patients. Results of a 1998 survey among 4,643 Belgian physicians. Acta Clin Belg. 2000, 55: 266-75.
Gottlieb NH, Guo JL, Blozis SA, Huang PP: Individual and contextual factors related to family practice residents' assessment and counselling for tobacco cessation. J Am Board Fam Pract. 2001, 14: 343-51.
Pizzo AM, Chellini E, Grazzini G, Cardone A, Badellino F: Italian general practitioners and smoking cessation strategies. Tumori. 2003, 89: 250-4.
McEwen A, West R, Owen L, Raw M: General practitioners' views on and referral to NHS smoking cessation services. Public Health. 2005, 119: 262-8. 10.1016/j.puhe.2004.05.016.
Hoving C, Mudde AN, de Vries H: Intention to adopt a smoking cessation expert system within a self-selected sample of Dutch general practitioner. Eur J Cancer Prev. 2006, 15 (1): 82-6. 10.1097/01.cej.0000186633.81753.8b.
Bremberg S, Nilstun T: Justifications of physicians' choice of action. Scand J Prim Health Care. 2005, 23: 102-8. 10.1080/02813430510018455.
Coleman T, Murphy E, Cheater F: Factors influencing discussion of smoking between general practitioners and patients who smoke: a qualitative study. Br J Gen Pract. 2000, 50: 207-10.
Tomlin Z, Humphrey C, Rogers S: General practitioners' perceptions of effective health care. BMJ. 1999, 318: 1532-5.
Coleman T, Cheater F, Murphy E: Qualitative study investigating the process of giving antismoking advice in general practice. Patient Educ Couns. 2004, 52: 159-63. 10.1016/S0738-3991(03)00020-X.
Bruce N, Burnett S: Prevention of lifestyle-related disease: general practitioners' views about their role, effectiveness and resources. Fam Pract. 1991, 8: 373-7. 10.1093/fampra/8.4.373.
Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Molken MP: Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modelling study. Value Health. 2005, 8: 178-90. 10.1111/j.1524-4733.2005.04008.x.
Frølich A, Talavera JA, Broadhead P, Dudley RA: A behavioral model of clinician responses to incentives to improve quality. Health Policy. 2007, 80: 179-93. 10.1016/j.healthpol.2006.03.001.
The economic consequences of alcohol abuse to society. Ministry of Interior and Health, Health Analyses. 1999, 10.
Peters MJ: Should smokers be refused surgery?. British Medical JournalBMJ. 2007, 334: 20-10.1136/bmj.39059.503495.68.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/10/121/prepub
We would like to acknowledge all the 47 GPs in the local area of Copenhagen who participated in the study. We would also like to acknowledge the following individuals for participating in the working group and for supporting the implementation of this study in the clinical day life: Rikke H Holm and Bente Nelbom, (Nurses from the Tobacco Cession Clinic); Finn Zierau, (Psychiatrist from the Alcohol Unit); Sanne Stausgaard (Patient Administrative Office); Jens Glindvad, Helle Rasmussen, Marianne Petersen and Kim Bo Christensen, (head nurses from the department of surgical gastroenterology and orthopaedics); Professor Jes Bruun Lauritzen (orthopaedic department); Jane Cracknell (Managing Editor, Cochrane Anaesthesia Review Group) for proofreading on linguistic and grammar.
Funding sources listed in descending order of the amount of grant given: Copenhagen Health Services, Bispebjerg Hospital, IMK Almene Fond, GP Board of Quality Management and Novartis.
HT, PF and HR have received funds for the present research as mentioned below. Bispebjerg Hospital, Copenhagen Health Services, GP Board of Quality Management, and Novartis might in some way, or to some degree, gain financially from the results. None of the funders took part in the design and conduct of the study; collection, management, analysis, interpretation of the data; preparation, review, or approval of the manuscript.
HT is a surgeon as well as director of the WHO Collaborating Centre for Evidence-Based Health in Hospitals; is working together with the National Board of Health and Danish Medical Association; is organising pre- and postgraduate education; and acts as peer reviewer on the subject for scientific journals.
PF is organising pre- and postgraduate education.
HR has no competing interest to be declared.
VB is associated professor, respiratory physician and chief of the respiratory research's unit as well as chief physician at the Tobacco Cession Unit.
DMN has no competing interest to be declared.
HT has made substantial contributions to conception and design, acquisition of data, and analysis and interpretation of data. HT has been involved in revising the manuscript critically for important intellectual content and has given final approval of the version to be published. PF and HR have made substantial contributions to conception and design and analysis and interpretation of data. Both have been involved in revising the manuscript critically for important intellectual content and have given final approval of the version to be published. VB has made substantial contributions to conception and design. VB has been involved in revising the manuscript critically for important intellectual content and has given final approval of the version to be published. DMN and GT have made substantial contributions to acquisition of data. Both have been involved in revising the manuscript critically for important intellectual content and have given final approval of the version to be published.